Revvity Inc RVTY

NYSE US Health Care Life Sciences Tools & Services

$151.11 ▲ +0.29% (+$0.43)

Index member: S&P 500

Open $150.70

Prev Close $150.68

Day Range $147.03 – $151.99

52W Range $81.22 – $152.26

Market Cap $16.37B

P/E (TTM) 69.95

Beta 1.10

Div Yield 0.31%

EPS (TTM) $2.10

📋 Company Profile

Industry	Life Sciences Tools & Services
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1965-07-06
Shares Out.	111,560,000
Website	revvity.com/ ↗
Phone	17816636900
Employees	11,000
Revenue	$729.7M
Gross Profit	$416.9M
Net Income	$51.8M
Free Cash Flow	$558.1M
Total Assets	$12.05B
Total Liabilities	$4.82B
Equity	$7.23B

About Revvity Inc

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Revvity Inc is a publicly traded company under the ticker symbol RVTY on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.